-
Product Insights
NewBeta 2 Adrenergic Receptor – Drugs In Development, 2024
The Beta 2 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Beta 2 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Ophthalmology, Immunology, and Cardiovascular which include indications of Asthma, Chronic Obstructive Pulmonary Disease (COPD), Ocular Hypertension, Open-Angle Glaucoma, Anaphylaxis, Allergies, Congestive Heart Failure (Heart Failure), and Hypertension. It also...
-
Product Insights
NewThyroid Hormone Receptor Beta – Drugs In Development, 2024
The Thyroid Hormone Receptor Beta pipeline drugs market research report outlays comprehensive information on the Thyroid Hormone Receptor Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Hormonal Disorders, and Central Nervous System which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Dyslipidemia, Obesity, Hypothyroidism, Multiple Sclerosis, and Unspecified...
-
Product Insights
NewInterleukin 12 Subunit Beta – Drugs In Development, 2024
The Interleukin 12 Subunit Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 12 Subunit Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Musculoskeletal Disorders, and Oncology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Psoriatic Arthritis, Axial Spondyloarthritis, Ovarian Cancer, and Prostate Cancer....
-
Product Insights
NewBeta Nerve Growth Factor – Drugs In Development, 2024
The Beta Nerve Growth Factor pipeline drugs market research report outlays comprehensive information on the Beta Nerve Growth Factor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Ophthalmology, Cardiovascular, and Hematological Disorders which include indications of Cancer Pain, Pain, Glaucoma, Optic Nerve Injury, Myocardial Infarction, Cardiac Arrest, and Sickle Cell Disease. It also reviews...
-
Product Insights
NewRetinoic Acid Receptor Beta – Drugs In Development, 2024
The Retinoic Acid Receptor Beta pipeline drugs market research report outlays comprehensive information on the Retinoic Acid Receptor Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Dermatology, Respiratory, Central Nervous System, and Oncology which include indications of Acne Vulgaris, Hand Dermatitis, Bronchopulmonary Dysplasia, Idiopathic Pulmonary Fibrosis, Amyotrophic Lateral Sclerosis, Spinal Cord Injury, Acute Myelocytic Leukemia (AML,...
-
Product Insights
NewTGF Beta Receptor Type 1 – Drugs In Development, 2024
The TGF Beta Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the TGF Beta Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Gastrointestinal which include indications of Solid Tumor, Esophageal Cancer, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Wounds, Keloids, Crohn's Disease (Regional Enteritis), and Oral Mucositis. It...
-
Product Insights
NewGlycogen Synthase Kinase 3 Beta – Drugs In Development, 2024
The Glycogen Synthase Kinase 3 Beta pipeline drugs market research report outlays comprehensive information on the Glycogen Synthase Kinase 3 Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Musculoskeletal Disorders, and Genetic Disorders which include indications of Alzheimer's Disease, Unspecified Central Nervous System Disorders, Lung Cancer, Pancreatic Cancer, Sarcopenia, Myotonic Dystrophy, Duchenne...
-
Product Insights
NewInterleukin 6 Receptor Subunit Beta – Drugs In Development, 2024
The Interleukin 6 Receptor Subunit Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 6 Receptor Subunit Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Musculoskeletal Disorders, Central Nervous System, and Immunology which include indications of Unspecified Cancer, Oncology, Osteoarthritis, Fibrosis, Multiple Sclerosis, Autoimmune Disorders, and Inflammation. It also reviews key players...
-
Product Insights
New17 Beta Hydroxysteroid Dehydrogenase 13 – Drugs In Development, 2024
The 17 Beta Hydroxysteroid Dehydrogenase 13 pipeline drugs market research report outlays comprehensive information on the 17 Beta Hydroxysteroid Dehydrogenase 13 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Liver Fibrosis. It also reviews key players involved in 17 Beta Hydroxysteroid Dehydrogenase 13 targeted therapeutics development with...
-
Product Insights
NewInterleukin 2 Receptor Subunit Beta – Drugs In Development, 2024
The Interleukin 2 Receptor Subunit Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 2 Receptor Subunit Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Infectious Disease which include indications of Solid Tumor, Unspecified Cancer, Graft Versus Host Disease (GVHD), Autoimmune Disorders, Vitiligo, Alopecia Areata, Coronavirus Disease 2019 (COVID-19),...